Keros Therapeutics
KROS
KROS
161 hedge funds and large institutions have $582M invested in Keros Therapeutics in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 74 increasing their positions, 30 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
2.39% less ownership
Funds ownership: 93.1% → 90.72% (-2.4%)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
71% less capital invested
Capital invested by funds: $2.03B → $582M (-$1.45B)
Holders
161
Holding in Top 10
2
Calls
$10.8M
Puts
$11.2M
Top Buyers
| 1 | +$18.8M | |
| 2 | +$10.2M | |
| 3 | +$8.61M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$8.44M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$7.11M |
Top Sellers
| 1 | -$30.5M | |
| 2 | -$23M | |
| 3 | -$20.1M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$16.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$15M |